We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$395B
AUM Growth
-$12B
Cap. Flow
-$5.37B
Cap. Flow %
-1.36%
Top 10 Hldgs %
10.91%
Holding
4,110
New
151
Increased
2,106
Reduced
1,588
Closed
95

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$895M
2
ADI icon
Analog Devices
ADI
+$737M
3
ZLAB icon
Zai Lab
ZLAB
+$472M
4
NTES icon
NetEase
NTES
+$465M
5
CSCO icon
Cisco
CSCO
+$440M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.48B
2
MXIM
Maxim Integrated Products
MXIM
+$898M
3
PG icon
Procter & Gamble
PG
+$567M
4
ORCL icon
Oracle
ORCL
+$478M
5
COF icon
Capital One
COF
+$459M

Sector Composition

Rank Sector Weight
1 Technology 20.29%
2 Financials 13.39%
3 Healthcare 12.62%
4 Consumer Discretionary 12.44%
5 Industrials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIM icon
3851
Neuronetics
STIM
$155M
$89K ﹤0.01%
13,510
-216,873
-94% -$2.08M
EOLS icon
3852
Evolus
EOLS
$398M
$88K ﹤0.01%
11,578
-141,492
-92% -$1.46M
FLNT
3853
Fluent
FLNT
$106M
$88K ﹤0.01%
6,480
+533
+9% +$8K
GTBP icon
3854
GT Biopharma
GTBP
$11.8M
$88K ﹤0.01%
433
+74
+21% +$22.3K
LOTZ
3855
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$86K ﹤0.01%
22,395
+4,810
+27% +$20.7K
AXDX
3856
DELISTED
Accelerate Diagnostics
AXDX
$85K ﹤0.01%
1,435
+292
+26% +$19K
CNEY icon
3857
CN Energy Group
CNEY
$4.93M
$85K ﹤0.01%
+19
New +$84.7K
PSTX
3858
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$85K ﹤0.01%
11,629
+954
+9% +$8.19K
ADVM
3859
DELISTED
Adverum Biotechnologies
ADVM
$82K ﹤0.01%
3,765
-196
-5% -$5K
FBIO icon
3860
Fortress Biotech
FBIO
$91.4M
$82K ﹤0.01%
1,702
+415
+32% +$20.3K
QTNT
3861
DELISTED
Quotient Limited Ordinary Shares
QTNT
$81K ﹤0.01%
872
+172
+25% +$21.5K
CARM
3862
DELISTED
Carisma Therapeutics
CARM
$79K ﹤0.01%
4,945
+1,301
+36% +$62.4K
CLOV icon
3863
Clover Health Investments
CLOV
$2.27B
$78K ﹤0.01%
10,610
-25
-0.2% -$214
IMDX
3864
Insight Molecular Diagnostics
IMDX
$168M
$78K ﹤0.01%
1,094
+151
+16% +$13.9K
MILE
3865
DELISTED
Metromile, Inc. Common Stock
MILE
$78K ﹤0.01%
22,049
+2,987
+16% +$16.9K
EVLO
3866
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$77K ﹤0.01%
+544
New +$108K
OUST icon
3867
Ouster
OUST
$3.18B
$76K ﹤0.01%
+1,035
New +$95.5K
WVE icon
3868
Wave Life Sciences
WVE
$1.17B
$76K ﹤0.01%
15,551
+3,004
+24% +$18.2K
EIGR
3869
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$76K ﹤0.01%
382
+45
+13% +$10.7K
BCEL
3870
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$76K ﹤0.01%
12,108
+1,134
+10% +$7.56K
EXK
3871
Endeavour Silver
EXK
$2.49B
$75K ﹤0.01%
18,315
-96
-0.5% -$460
JFU
3872
9F Inc
JFU
$28.8M
$74K ﹤0.01%
+2,166
New +$81.5K
IBIO icon
3873
iBio
IBIO
$73M
$72K ﹤0.01%
136
+23
+20% +$14.3K
WNW icon
3874
Meiwu Technology Co
WNW
$66.1M
0
AQB icon
3875
AquaBounty Technologies
AQB
$4.66M
$70K ﹤0.01%
863
+172
+25% +$16.1K

Similar funds

Invesco's Q3 2021 Portfolio in Review

As of Q3 2021, Invesco held 4,110 positions worth $395B, down 2.9% from $407B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Invesco's Q3 2021 filing shows 151 new, 2,106 increased, 1,588 reduced and 95 closed positions. Its largest new stake was GXO Logistics: 973,368 shares worth $76.4M. The largest sale was Alibaba, an estimated $1.48B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q3 2021 buy was GXO Logistics: 973,368 shares worth $76.4M.
  • Invesco added most to Salesforce in Q3 2021, an estimated $895M increase.
  • Invesco's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.48B.
  • Invesco fully exited Maxim Integrated Products in Q3 2021, selling an estimated $898M.
  • Invesco's ten largest holdings make up 11% of its $395B portfolio in Q3 2021.
  • Invesco opened 151 new positions and closed 95 in Q3 2021.
  • Invesco's portfolio value fell 2.9% quarter-over-quarter to $395B.

Based on Invesco's 13F filing for Q3 2021, filed 15 Nov 2021.